✦ LIBER ✦

Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol)

✍ Scribed by Luciano Adorini; Giuseppe Penna; Susana Amuchastegui; Chiara Cossetti; Francesca Aquilano; Roberto Mariani; Benedetta Fibbi; Annamaria Morelli; Milan Uskokovic; Enrico Colli; Mario Maggi

Book ID: 116697965
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 297 KB
Volume: 103
Category: Article
ISSN: 0960-0760
DOI: 10.1016/j.jsbmb.2006.12.065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-clinical evidence and clinical trans

Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol)

✍ Maggi, M.; Crescioli, C.; Morelli, A.; Colli, E.; Adorini, L. 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 163 KB

The vitamin D analogue BXL-628 inhibits

The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells

✍ Sara Marchiani; Lorella Bonaccorsi; Pietro Ferruzzi; Clara Crescioli; Monica Mur 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 309 KB

Inhibition of primary colon carcinoma gr

Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101

✍ Ohana, G; Bar-Yehuda, S; Arich, A; Madi, L; Dreznick, Z; Rath-Wolfson, L; Silber 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 183 KB